Processing

Please wait...

Settings

Settings

Goto Application

1. IL192973 - CONTROLLED RELEASE DOSAGE FORM COMPRISING A MATRIX FORMULATION COMPRISING OXYCODONE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE FOR USE TO PREVENT FORMATION OF AN EXTRACT OF SAID MATRIX FORMULATION

Office
Israel
Application Number 192973
Application Date 22.07.2008
Publication Number 192973
Publication Date 11.02.2009
Grant Number
Grant Date 30.04.2014
Publication Kind B
CPC
A61K 9/1694
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
16Agglomerates; Granulates; Microbeadlets ; ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
1682Processes
1694resulting in granules or microspheres of the matrix type containing more than 5% of excipient
A61K 9/2013
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2004Excipients; Inactive ingredients
2013Organic compounds, e.g. phospholipids, fats
A61K 9/2054
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
2004Excipients; Inactive ingredients
2022Organic macromolecular compounds
205Polysaccharides, e.g. alginate, gums; Cyclodextrin
2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
A61K 31/485
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
485Morphinan derivatives, e.g. morphine, codeine
A61P 25/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
04Centrally acting analgesics, e.g. opioids
A61P 25/36
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
30for treating abuse or dependence
36Opioid-abuse
Applicants EURO-CELTIQUE S.A.
Priority Data 06001754 27.01.2006 EP
Title
(EN) CONTROLLED RELEASE DOSAGE FORM COMPRISING A MATRIX FORMULATION COMPRISING OXYCODONE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE FOR USE TO PREVENT FORMATION OF AN EXTRACT OF SAID MATRIX FORMULATION
(HE) צורת מינון לשחרור מבוקר המכילה מטריקס פורמולציה הכוללת אוקסיקודון הידרוכלוריד ונלוקסון הידרוכלוריד לשימוש למניעה של היווצרות של מצוי של המטריקס פורמולציה
Abstract
(EN)